Info-tech

Competition panel clears Micromax-Madison India deal

Venkatesan R | | Updated on: Dec 27, 2016

The Competition Commission of India has cleared the proposed purchase of 2 per cent stake in handset maker Micromax by Madison India Opportunities Trust Fund (MIOTF), besides three other deals involving different companies.

In a tweet, the watchdog said it has approved “acquisition of equity stake in Micromax Informatics Ltd by Madison India Opportunities Trust Fund”.

MIOTF is registered with capital market regulator as an Alternative Investment Fund.

Separately, the CCI has given its nod to ICU Medical Inc buying drug major Pfizer’s hospira infusion systems business.

Post deal, Pfizer would own around 16.6 percent of ICU Medical, as per a release issued by the drug maker in October.

The fair trade regulator has also given the green signal for the proposed joint venture between TDK Corp and Toshiba Corp.

According to a filing by the companies to the watchdog, Toshiba would hold 25 per cent shares in the joint venture and the remaining 75 per cent would be with TDK.

The joint venture named TDK Automotive Technologies Corporation, would engage in the development, manufacture and sales of automotive inverters for hybrid vehicles, plug-in hybrid vehicles and electric vehicles, a Toshiba press release had said.

Both companies have India presence.

The acquisition of stake in Gestamp Automocion S A by Mitsui & Co has also been cleared by the regulator.

“CCI India approves acquisition of 12.525 per cent stake in Gestamp Automocion S A by Mitsui & Co Ltd,” another tweet said.

Mitsui, through its subsidiaries, is mainly engaged in the field of import and export related transactions and various manufacturing and sales operations with Indian companies.

Gestamp Automocion S.A is into automotive components and assemblies.

Both entities have presence in India.

Published on January 16, 2018

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

COMMENTS
This article is closed for comments.
Please Email the Editor

You May Also Like

Recommended for you